Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(7 sites)
France
Amiens University Hospital, Amiens Angers University Hospital, Angers Bordeaux University Hospital, Bordeaux Centre Georges François Leclerc, Dijon Uhmontpellier, Montpellier Hôpital Européen Georges Pompidou, Paris Institut Gustave Roussy, Villejuif Age range
18 Years and older
Last updated January 2026